ATE398627T1 - C-2-modifizierte erythromycinderivate - Google Patents

C-2-modifizierte erythromycinderivate

Info

Publication number: ATE398627T1
Authority: AT; Austria
Prior art keywords: compound; formula; erythromycin derivatives; bacterial infections; treating bacterial
Prior art date: 1999-05-14

Application number

AT00930370T

Other languages

English (en)

Inventor

Zhenkun Ma

Yat OR

Ly Phan

Suoming Zhang

Richard Clark

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-14

Filing date

2000-05-04

Publication date

2008-07-15

2000-05-04 Application filed by Abbott Lab filed Critical Abbott Lab

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE398627T1 publication Critical patent/ATE398627T1/de

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 5
208000035143 Bacterial infection Diseases 0.000 abstract 2
208000022362 bacterial infectious disease Diseases 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
150000002148 esters Chemical class 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT00930370T 1999-05-14 2000-05-04 C-2-modifizierte erythromycinderivate ATE398627T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/312,517 US6355620B1 (en)	1999-05-14	1999-05-14	C-2 modified erythromycin derivatives

Publications (1)

Publication Number	Publication Date
ATE398627T1 true ATE398627T1 (de)	2008-07-15

Family

ID=23211820

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00930370T ATE398627T1 (de)	1999-05-14	2000-05-04	C-2-modifizierte erythromycinderivate

Country Status (11)

Country	Link
US (1)	US6355620B1 (de)
EP (1)	EP1181299B1 (de)
JP (1)	JP2002544284A (de)
AT (1)	ATE398627T1 (de)
CA (1)	CA2372270C (de)
DE (1)	DE60039238D1 (de)
DK (1)	DK1181299T3 (de)
ES (1)	ES2307511T3 (de)
MX (1)	MXPA01011633A (de)
PT (1)	PT1181299E (de)
WO (1)	WO2000069875A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2359708C (en)	1999-01-27	2005-10-25	Pfizer Products Inc.	Ketolide antibiotics
HUP0201516A3 (en) *	1999-05-24	2003-03-28	Pfizer Prod Inc	13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
EP1167376B1 (de) *	2000-06-30	2004-07-14	Pfizer Products Inc.	Makrolid-Antibiotika
US20040077557A1 (en) *	2000-12-21	2004-04-22	Sulejman Ali	Macrolide antibiotics
DE10122139A1 (de) *	2001-05-08	2002-11-21	Daniel Swarovski	Verfahren und Vorrichtung zur Bestimmung der Verteilung von Inhaltsstoffen in fluiden Medien
AU2002346475A1 (en)	2001-12-05	2003-06-23	Ortho-Mcneil Pharmaceutical, Inc.	6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US7910558B2 (en) *	2002-05-13	2011-03-22	Enanta Pharmaceuticals, Inc.	Bridged macrocyclic compounds and processes for the preparation thereof
US6841664B2 (en) *	2002-07-25	2005-01-11	Enanra Pharmaceuticals, Inc.	6,11-4-carbon bridged ketolides
US7273853B2 (en) *	2002-05-13	2007-09-25	Enanta Pharmaceuticals, Inc.	6-11 bicyclic ketolide derivatives
US7163924B2 (en)	2003-04-25	2007-01-16	Chiron Corporation	Ketolide derivatives
US7414030B2 (en) *	2004-01-07	2008-08-19	Enanta Pharmaceuticals, Inc.	6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) *	2004-01-09	2005-08-04	Enanta Pharmaceuticals, Inc.	9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) *	2004-02-20	2008-06-10	Enanta Pharmaceuticals, Inc.	Polymorphic forms of 6-11 bicyclic ketolide derivatives
WO2005121160A2 (en) *	2004-04-26	2005-12-22	Johnson & Johnson Pharmaceutical Research & Development	11, 12 cyclic thiocarbamate macrolide antibacterial agents
WO2006065743A2 (en) *	2004-12-13	2006-06-22	Enanta Pharmaceuticals, Inc.	Tetracylic bicyclolides
UA85937C2 (uk) *	2004-12-21	2009-03-10	Пфайзер Продактс Інк.	Макроліди
US20060252710A1 (en) *	2005-05-04	2006-11-09	Guoqiang Wang	6-11 Bridged oxime erythromycin derivatives
US7384922B2 (en) *	2005-05-04	2008-06-10	Enanta Pharmaceuticals, Inc.	6-11 bridged oxime erythromycin derivatives
JPWO2009019868A1 (ja)	2007-08-06	2010-10-28	大正製薬株式会社	１０ａ、１２位架橋型１０ａ−アザライド化合物
US8273720B2 (en) *	2007-09-17	2012-09-25	Enanta Pharmaceuticals, Inc.	6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) *	2007-09-17	2013-01-15	Enanta Pharmaceuticals, Inc.	6,11-bridged biaryl macrolides
EP2203435B1 (de) *	2007-09-17	2018-07-18	Enanta Pharmaceuticals, Inc.	6, 11-gebrückte biaryl-makrolide
TW200946109A (en) *	2008-05-09	2009-11-16	Enanta Pharm Inc	Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
US8299035B2 (en)	2008-05-15	2012-10-30	Taisho Pharmaceutucal Co., Ltd.	10a-azalide compound having 4-membered ring structure
CN104650166B (zh) *	2014-11-17	2017-12-05	广东东阳光药业有限公司	一种大环内酯的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
EP0559896B1 (de)	1990-11-28	1997-08-27	Taisho Pharmaceutical Co. Ltd	6-0-methylerythromycin a-derivat
ATE135707T1 (de)	1992-04-22	1996-04-15	Taisho Pharmaceutical Co Ltd	5-0-desosaminylerythronolid a derivate
FR2742757B1 (fr)	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5940488A (en) *	1996-11-15	1999-08-17	Active Voice Corporation	Telecommunication management system and user interface
BR9812577A (pt) *	1997-09-30	2000-10-17	Abbott Lab	Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas

1999
- 1999-05-14 US US09/312,517 patent/US6355620B1/en not_active Expired - Lifetime
2000
- 2000-05-04 EP EP00930370A patent/EP1181299B1/de not_active Expired - Lifetime
- 2000-05-04 ES ES00930370T patent/ES2307511T3/es not_active Expired - Lifetime
- 2000-05-04 DE DE60039238T patent/DE60039238D1/de not_active Expired - Fee Related
- 2000-05-04 PT PT00930370T patent/PT1181299E/pt unknown
- 2000-05-04 WO PCT/US2000/012202 patent/WO2000069875A1/en not_active Ceased
- 2000-05-04 AT AT00930370T patent/ATE398627T1/de not_active IP Right Cessation
- 2000-05-04 DK DK00930370T patent/DK1181299T3/da active
- 2000-05-04 CA CA002372270A patent/CA2372270C/en not_active Expired - Fee Related
- 2000-05-04 JP JP2000618291A patent/JP2002544284A/ja active Pending
- 2000-05-04 MX MXPA01011633A patent/MXPA01011633A/es active IP Right Grant

Also Published As

Publication number	Publication date
US6355620B1 (en)	2002-03-12
MXPA01011633A (es)	2002-07-30
EP1181299B1 (de)	2008-06-18
DK1181299T3 (da)	2008-10-27
EP1181299A1 (de)	2002-02-27
WO2000069875A1 (en)	2000-11-23
CA2372270C (en)	2008-07-22
WO2000069875A9 (en)	2002-02-21
JP2002544284A (ja)	2002-12-24
CA2372270A1 (en)	2000-11-23
PT1181299E (pt)	2008-09-18
DE60039238D1 (de)	2008-07-31
ES2307511T3 (es)	2008-12-01

Legal Events

Date

Code

Title

Description

2009-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1181299

Country of ref document: EP

2010-08-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60039238D1 (de)	2008-07-31	C-2-modifizierte erythromycinderivate
WO2004062601A3 (en)	2005-04-21	Antibacterial agents
CA2392973A1 (en)	2001-06-07	Benzoimidazole derivatives useful as antiproliferative agents
TR199901127T2 (xx)	1999-07-21	Antibakteriyel etkili 6-O-ikameli ketolitler.
NO996108L (no)	2000-02-10	9-oksinerytromycinderivater
CA2413424A1 (en)	2001-12-27	Substituted bicyclic derivatives for the treatment of abnormal cell growth
NO20015172L (no)	2002-01-23	1-metyl-erytromycin-derivater
DK1021456T3 (da)	2003-08-18	Makrocykliske derivater af erythromysin A og B med 13-leddet ring
IL165715A0 (en)	2006-01-15	2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
CA2478374A1 (en)	2003-09-25	N3 alkylated benzimidazole derivatives as mek inhibitors
AP9801378A0 (en)	2000-04-29	9-amino-3- keto erythromycin derivatives.
WO2004096823A3 (en)	2005-02-10	Novel ketolide derivatives
MX2009006334A (es)	2009-06-23	Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona.
NO20052074L (no)	2005-06-01	Substituerte benzoksazinoner og anvendelser derav.
DK0992509T3 (da)	2004-12-20	Nye makrolid-derivater
GEP20084437B (en)	2008-07-25	Novel lincomycin derivatives possessing antimicrobial activity
NO20054135L (no)	2005-09-23	Kipolinon/benzoksazin derivater og anvendelser derav
BR9708929A (pt)	1999-08-03	Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
EP1109560A4 (de)	2002-04-17	Als inhibitoren der aicarftnützliche verbindungen
AP9801377A0 (en)	2000-04-29	Tricyclic erythromycin derivatives.
WO2003057213A3 (en)	2004-02-19	Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
AP2001002325A0 (en)	2001-12-31	Novel crystalline forms of a macrolide antibiotic
WO2002018353A3 (en)	2002-06-13	Oxazolidinone chemotherapeutic agents
TR200201145T2 (tr)	2002-09-23	Hidromisin türevleri
NZ515278A (en)	2003-06-30	Halo derivatives of 9-deoxo-9a-aza-9a- homerythromycin A their salts and preparation process